Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-17 Sale |
2021-08-19 5:49 pm |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
14,779 | $47.56 | $702,889 | 72,021 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
35,656 | $1.16 | 167,590 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
13,767 | $0.87 | 167,590 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A 2023-09-26 |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
100,479 | $0 | 167,590 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
15,725 | $1.89 | 167,590 (Direct) |
View |
| 2022-11-16 Exercise |
2022-11-17 6:24 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief R&D Strategy Officer |
35,331 | $4.21 | 167,590 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-03-02 8:38 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
2,119 | $24.28 | 66,538 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:25 pm |
N/A 2032-02-14 |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
70,000 | $0 | 128,657 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 5:49 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
10,000 | $0.87 | 72,021 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 5:49 pm |
N/A 2023-09-26 |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
10,000 | $0 | 72,021 (Direct) |
View |
| 2021-02-26 Option Award |
2021-02-26 6:31 pm |
N/A 2031-02-25 |
Protagonist Therapeutics Inc | PTGX | Liu David Y Chief Scientific Officer |
75,000 | $0 | 127,427 (Direct) |
View |